The United States Department of Justice has issued grand jury subpoenas to multiple healthcare institutions, including NYU Langone, to obtain records pertaining to gender-affirming care administered to minors.

美國司法部已向包括紐約大學朗格尼醫療中心（NYU Langone）在內的多家醫療機構發出大陪審團傳票，以獲取與未成年人接受性別肯定醫療相關的紀錄。

The current investigative phase represents a transition from previous administrative inquiries to criminal proceedings. While the Department of Justice previously issued civil subpoenas to approximately 20 institutions, the recent directives from the U.S. Attorney’s Office for the Northern District of Texas necessitate the disclosure of patient identities and clinician data for the period between 2020 and 2026. This shift toward grand jury oversight implies a higher threshold of legal scrutiny and the potential for more severe penalties.

目前的調查階段代表從之前的行政查詢轉向刑事程序。雖然司法部先前向約 20 家機構發出了民事傳票，但德克薩斯州北區聯邦檢察官辦公室最近的指令要求披露 2020 年至 2026 年期間的患者身份與臨床醫生數據。這種向大陪審團監督的轉移，意味著更高的法律審查門檻以及可能面臨更嚴厲的處罰。

Institutional and jurisdictional tensions have emerged regarding the legitimacy of these requests. Legal analysts have characterized the utilization of a Texas-based court to subpoena a New York institution as a strategic selection of jurisdiction to secure favorable judicial outcomes. Furthermore, the NYU Langone subpoena serves as a potential challenge to New York's shield laws, which mandate a 30-day notification period for patients prior to the release of medical records to judicial entities.

針對這些請求的合法性，機構與司法管轄區之間出現了緊張局勢。法律分析師將利用德州法院傳喚紐約機構的行為，描述為一種為了獲取有利司法結果的策略性管轄區選擇。此外，對 NYU Langone 的傳票可能對紐約州的「遮蔽法」（shield laws）構成挑戰，該法規定在將醫療紀錄提供給司法實體前，必須給予患者 30 天的通知期。

Stakeholder positioning reveals a dichotomy between federal objectives and judicial precedents. The administration has postulated that the off-label promotion of puberty blockers and hormones may constitute healthcare fraud. Conversely, proponents of the care cite a Seattle federal court ruling that vacated a Department of Health and Human Services declaration regarding medical standards of care. Despite these judicial setbacks, DOJ representatives have asserted that the vacating of federal guidance will not impede ongoing criminal investigations. Consequently, several medical facilities have suspended transgender services, citing the cumulative pressure of federal litigation and funding threats.

利益相關者的定位揭示了聯邦目標與司法先例之間的對立。政府假設，標記外（off-label）推廣青春期阻斷劑與荷爾蒙治療可能構成醫療欺詐。相反，該療法的支持者引用西雅圖聯邦法院的一項裁決，該裁決廢止了衛生及公共服務部關於醫療護理標準的聲明。儘管遭遇這些司法挫折，司法部代表仍聲稱，聯邦指引的廢止不會妨礙正在進行的刑事調查。因此，數家醫療機構以聯邦訴訟與資金威脅的累積壓力為由，暫停了跨性別服務。

The federal government continues to pursue criminal investigations into pediatric gender care, while healthcare providers and patient advocates utilize judicial challenges and state shield laws to obstruct the acquisition of private medical data.

聯邦政府持續對兒童性別醫療進行刑事調查，而醫療提供者與患者倡導者則利用司法挑戰與州遮蔽法來阻撓私人醫療數據的獲取。